Please sign up for SocialPicks site access - it's free!
SocialPicks Sentiment:
** v.s.
other stocks
|
This Quarter's Sentiment:
|
|
|
ARQL Analysis & Videos »
ARQL: Bull or Bear?
FDA, Clinical Trial News: $ARQL $ESALY $GETA.OB $ABT
ARQL
|
|
|
-22.78%
in
796 days
Shares of cancer drug developer ArQule (NASDAQ:ARQL) are more than doubling today on news of a 66% improvement in median progression-free survival (PFS) for non-small cell lung cancer patients (NSCLC) in combination with Tarceva (erlotinib) with complete data to be presented later this year and used for design of pending Phase 3 studies. In addition, data from a Phase 2 study in patients with soft tissue sarcoma is expected during by mid-2010. <> <font> Eisai (OTC:ESALY) announced that it has submitted simultaneous regulatory filings in the US, EU, and Japan for the treatment of locally ad...
|
Navigating the Minefield of Micro-Cap Biotechs
ARQL
|
|
|
+149.47%
in
493 days
(closed on 03/31/10)
<>  The accompanying table includes 52 companies with market caps below the $150M minimum for inclusion in the ETF Innovators [ETFI] Emerging Bio-Pharma Index . While the performance is terrible with an average loss of nearly 50%, keep in mind that several buyouts in the out-of-favor micro-cap biotech space have been announced over the past year with 100%-plus takeover premiums, including under-the-radar names such as:
1.) SGX Pharma (SGXP) was acquired for $64M cash by Eli Lilly (LLY) for its cancer drug discovery...
|
ARQL
ARQL
|
|
|
-41.03%
in
1840 days
Hmmm positive stock price movement ahead of ASCO, heavy insider buying since march, well, no really significant news (yet). Does anyone expect something big? at ASCO maybe? About ARQ 192 maybe (Kyowa's deal probably is an indicator that the drug could be something big, especially at such an early stage of development).
|
People Bullish on ARQL
People Bearish on ARQL
|
ROCK-STAR INVESTORS
|
|
POPULAR STOCKS
|
|
TODAY'S HEADLINES
|
|
TODAY'S TOP PICKS
|
|
|
| StreetInsider.com on ARQL |
Be the first to start a discussion and earn 2 points.
More Resources
|
About ArQule Inc.
- Answers.com
